EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia

Nino Maghradze iD, Chloé Loiseau, Galo Adrian Goig, Nino Bablishvili, Levan Jugheli, Sonia Borrell, Nestani Tukvadze, Russell Ryan Kempker iD, Zaza Avaliani, Sebastien Gagneux iD

PLOS One · 15.07.2025 · 20 (7) · e0326794

DOI: 10.1371/journal.pone.0326794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 15.07.2025. Verfasst von Nino Maghradze und 9 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute, Basel, Switzerland. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Diarylquinolines, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, H2020 European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Resistance to bedaquiline – a novel, promising medication against tuberculosis (TB), is already emerging, and uncertainties regarding the role of the different resistance-conferring mutations complicate the development of molecular diagnostic tools for detecting resistance. Mutations in the three genes atpE, pepQ, and Rv0678 have been associated with increased minimum inhibitory concentrations (MICs) to bedaquiline in Mycobacterium tuberculosis (Mtb). Here, we studied the effect of known and novel mutations in these genes on the phenotypic susceptibility to bedaquiline in Mtb isolates from patients with drug-resistant TB in the country of Georgia.

Methods

We used retrospective Mtb isolates (2011–2019) with whole-genome sequencing data, and prospectively collected diagnostic isolates with phenotypic resistance (2019–2022) to bedaquiline at the Georgian National Reference Laboratory. We determined bedaquiline MIC values using the Sensititre TM MYCOTB MIC plate. MIC of 0.12 μg/mL was defined as borderline and MIC ≥ 0.25 μg/mL as a resistant isolate. A phylogeny was inferred to assess the likely role of the identified variants in bedaquiline resistance, while taking into consideration population structure of the strains analyzed.

Results

We analyzed a total of 69 Mtb isolates and identified 61 mutations across the three target genes. Seventeen (27.8%) of these variants were associated with borderline (0.12 μg/mL) or resistant (≥0.25 μg/mL) MICs to bedaquiline. In addition to six previously described bedaquiline resistance-conferring mutations in atpE and Rv0678 , we identified two novel variants in Rv0678 (Leu95Ser and Ile108fs) likely involved in bedaquiline resistance. We found a Tyr92Cys mutation in Rv0678 in two epidemiologically linked isolates, which likely emerged as a consequence of previous exposure to clofazimine.

Conclusion

Consistent with previous reports, our study confirms that mutations in Rv0678 are the most frequent cause of bedaquiline resistance in Georgia, in addition to an increasing clinical relevance of mutations in atpE , while the role of pepQ mutations remains to be defined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisDiarylquinolinesAntitubercular AgentsTuberculosis, Multidrug-ResistantDrug Resistance, BacterialHumansMicrobial Sensitivity TestsGeorgia (Republic)MutationPhenotypeRetrospective StudiesBacterial ProteinsWhole Genome SequencingPhylogeny

Substanzen

bedaquilineDiarylquinolinesAntitubercular AgentsBacterial Proteins

Autor:innen und Institutionen

  • Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • University of Basel, Basel, Switzerland.
  • National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.
  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Departments of Epidemiology and Global Health, Rollins School of Public Health of Emory University, Atlanta, Georgia, United States of America.

ORCID-Profile: Nino Maghradze, Russell Ryan Kempker, Sebastien Gagneux

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS
  • H2020 European Research Council

Zitieren

APA

Maghradze, N., Loiseau, C., Goig, G. A., Bablishvili, N., Jugheli, L., Borrell, S., Tukvadze, N., Kempker, R. R., Avaliani, Z., & Gagneux, S. (2025). Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia. PLOS One, 20(7), e0326794. https://doi.org/10.1371/journal.pone.0326794

Vancouver

Maghradze N, Loiseau C, Goig GA, Bablishvili N, Jugheli L, Borrell S, et al. Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia. PLOS One. 2025;20(7):e0326794. doi:10.1371/journal.pone.0326794

BibTeX
@article{Maghradze2025,
  author = {Maghradze, Nino and Loiseau, Chloé and Goig, Galo Adrian and Bablishvili, Nino and Jugheli, Levan and Borrell, Sonia and Tukvadze, Nestani and Kempker, Russell Ryan and Avaliani, Zaza and Gagneux, Sebastien},
  title = {Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {7},
  pages = {e0326794},
  doi = {10.1371/journal.pone.0326794}
}
Kostenlos starten →